The Next Generation Sequencing market report delivers strategic insights on the major developments unfolding in the industry. The global market is segmented on the basis of Product, Service, Application, End User, and provides in-depth research of the existing and upcoming market conditions.
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The demand for next generation sequencing technology has been increasing widely due to the rise in genetic tests. The availability of next generation sequencing at low cost, technological advancements and high prevalence of cancer cases during the previous years. Also, the companies operating the next generation sequencing market have been investing substantial time and amount in research and development activities, through which better technologies can be introduced in the market.
Get Sample Copy of the Report at – https://www.theinsightpartners.com/sample/TIPHE100000820/
The major players operating in the market of next generation sequencing market include F. Hoffmann-La Roche AG, PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Eurofins Scientific, Thermo Fisher Scientific, Beijing Genomics Institute, Agilent Technologies, Qiagen N.V., Macrogen, Inc., and Illumina, Inc. among others
In our study, we have segmented the next generation sequencing market by product, service, application and end-users. The products considered in the study are platform, services, and consumables. The platform segment is further segmented as Hiseq, Miseq, Solid, ION Torrent, Pacbio Rs II & Sequel Systems. The sub-segment of services is further divided as sequencing services and data management & analysis services. Consumables is further bifurcated as sample preparation consumables, library preparation & target enrichment kits & reagents, and quality control kits & reagents. The services segment is classified as genome sequencing. Exome sequencing, resequencing & targeted sequencing, and other services. The applications of next generation sequencing covered in the report include, diagnostics, drug discovery, precision medicine, and others. The end-users of next generation sequencing is classified as academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and others. Geographically, the market for next generation sequencing is categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
The next generation sequencing market is witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The companies operating in the market of next generation sequencing provide their products and services for applications such as drug discovery, diagnosis, and precision medicine. With constant R&D activities, the companies have been focusing towards developing advanced techniques in next generation sequencing that can be useful for end users such as hospitals & clinics, academic institutions, etc. Various players have been upgrading their product portfolio by applying for approvals. With expansion activities, companies are focusing towards strengthening their customer base by providing services to varied applications.
The next generation sequencing market is well established in North America region, especially in the U.S and Canada. Companies are engaging in expansion activities in order to strengthen their customer presence in the region of North America, For instance, Illumina, Inc. and Telegraph together launched a new company, Verogen, which would provide Illumina’s forensic sequencing technology to forensic customers in the US. Advancements in technologies and declining prices are considered to be the driving factors in the next generation sequencing market.
Purchase this Report at – https://www.theinsightpartners.com/buy/TIPHE100000820/
The most vital key factors in the businesses have been elaborated to get thorough and accurate data of market dynamics. Rising needs and popularity of Next Generation Sequencing Market sector is driving the flow of the market towards progress. In addition to this, it lists the factors which are restraining the growth of the market.
Reason to Buy
– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Next Generation Sequencing Market
– Highlights key business priorities in order to assist companies to realign their business strategies.
– The key findings and recommendations highlight crucial progressive industry trends in the Next Generation Sequencing Market, thereby allowing players to develop effective long term strategies.
– Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the straties that underpin commercial interest with respect to products, segmentation and industry verticals.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: [email protected]
Website: https://www.theinsightpartners.com/
